Acute rejection after liver transplantation despite intragraft coating by interleukin-2 receptor-alpha with basiliximab.
Kwekkeboom
J
J
Department of Hepatogastroenterology, University Hospital, Rotterdam, The Netherlands.
Maas
M
M
Rietveld
J H
JH
Zondervan
P E
PE
Bouma
G J
GJ
Tilanus
H W
HW
Metselaar
H J
HJ
D000208:Acute Disease; D000911:Antibodies, Monoclonal / Q000276:immunology / Q000627:therapeutic use*; D000077552:Basiliximab; D006084:Graft Rejection / Q000276:immunology* / Q000517:prevention & control; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016031:Liver Transplantation / Q000276:immunology*; D015375:Receptors, Interleukin-2 / Q000276:immunology*; D011993:Recombinant Fusion Proteins
D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents; D015375:Receptors, Interleukin-2; D011993:Recombinant Fusion Proteins; D000077552:Basiliximab